Rating History for Cyclacel Pharmaceuticals (CYCC) by Brookline Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/19/2023 | Kumaraguru Raja | Downgrade | Hold (Buy) |
N/A (N/A) |
3.69 (6.37) |
72.63% | Details |
 |
|||||||
|
|||||||
